- Home
- ICCT vs INDP Comparison
ICCT vs INDP Comparison
Compare ICCT & INDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICCT
- INDP
- Stock Information
- Founded
- ICCT 1992
- INDP 2000
- Country
- ICCT United States
- INDP United States
- Employees
- ICCT N/A
- INDP N/A
- Industry
- ICCT Computer Software: Prepackaged Software
- INDP Biotechnology: Pharmaceutical Preparations
- Sector
- ICCT Technology
- INDP Health Care
- Exchange
- ICCT Nasdaq
- INDP Nasdaq
- Market Cap
- ICCT 6.7M
- INDP 7.4M
- IPO Year
- ICCT N/A
- INDP N/A
- Fundamental
- Price
- ICCT $2.60
- INDP $0.47
- Analyst Decision
- ICCT
- INDP Strong Buy
- Analyst Count
- ICCT 0
- INDP 2
- Target Price
- ICCT N/A
- INDP $8.50
- AVG Volume (30 Days)
- ICCT 49.6M
- INDP 71.1K
- Earning Date
- ICCT 05-14-2025
- INDP 05-07-2025
- Dividend Yield
- ICCT N/A
- INDP N/A
- EPS Growth
- ICCT N/A
- INDP N/A
- EPS
- ICCT N/A
- INDP N/A
- Revenue
- ICCT $11,049,477.00
- INDP N/A
- Revenue This Year
- ICCT N/A
- INDP N/A
- Revenue Next Year
- ICCT N/A
- INDP N/A
- P/E Ratio
- ICCT N/A
- INDP N/A
- Revenue Growth
- ICCT 42.66
- INDP N/A
- 52 Week Low
- ICCT $0.24
- INDP $0.43
- 52 Week High
- ICCT $27.80
- INDP $3.10
- Technical
- Relative Strength Index (RSI)
- ICCT 49.97
- INDP 36.28
- Support Level
- ICCT $1.84
- INDP $0.45
- Resistance Level
- ICCT $3.57
- INDP $0.53
- Average True Range (ATR)
- ICCT 1.24
- INDP 0.04
- MACD
- ICCT -0.17
- INDP 0.01
- Stochastic Oscillator
- ICCT 11.95
- INDP 41.41
About ICCT iCoreConnect Inc. Common stock
iCoreConnect Inc develops and markets secure cloud-based HIPAA compliant software services focused on compliance, workflow/productivity, and electronic health records systems. Its core services technology can be adopted to other vertical markets that require a high degree of secure data communication, such as the legal, financial, and education fields. It markets secure HIPAA compliant cloud-based software as a service (SaaS) offering under the names of iCoreExchange, iCoreCodeGenius, iCoreSecure, iCoreMD, iCoreDental, iCoreMobile, iCoreHuddle, iCoreRx, iCorePDMP, iCoreEPCS, and iCorePay. The company's software is sold under annual recurring revenue subscriptions. The company has a single reporting segment for reporting purposes focused on the North American market.
About INDP Indaptus Therapeutics Inc.
Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.